S&P 600 SmallCap

935,46
-8,86
-0,94%
<
Kurse + Charts + Realtime
Snapshot
Historisch
>
<
Nachrichten
Marktberichte
Analysen
>
12.12.2006 13:00:00

Veeco Co-Sponsors the First AFM BioMed Conference

Veeco Instruments Inc. (Nasdaq: VECO) announced today that it will co-sponsor the first "AFM BioMed Conference,” to be held in Barcelona, Spain on April 19-21, 2007. This conference, the first of its kind, will be dedicated exclusively to life science applications, in order to investigate how atomic force microscopy (AFM) technology can solve relevant biological bottlenecks and provide innovative solutions for healthcare. The conference will link International academic and industrial experts in life sciences, being involved in AFM and related techniques in medical/biological studies. Abstracts for paper and poster presentations are now being accepted. Abstract and conference registration details are available at www.afmbiomed.org. The conference is also sponsored by Leica Microsystem, a leading supplier of high-resolution optic systems, and Telstar Instrumat. Pierre Parot, Chairman of the AFM BioMed Conference organizing committee, commented, "We expect that this conference will be a unique forum for scientists to share their latest advances in using AFM and other microscopy techniques in life science applications. We expect that the conference, which will include oral presentations, poster sessions and discussion forums, will draw a worldwide attendance from leading bio medical universities and research centers.” The scientific committee includes the conference organizers: Pierre Parot and Jean-Luc Pellequer, CEA/DSV (Life Science division of the Atomic Energy Commission), France and Daniel Navajas, University of Barcelona, Spain; and the session chairmen Yves Dufrêne, Catholic University of Louvain, Belgium; Peter Hinterdorfer, Johannes Kepler University, Austria; Simon Scheuring, Curie Institute, France and Christian Le Grimellec, INSERM (National Institute of Health and Medical Research), France. The three day conference will be divided into four sessions, as follows: Session I: Cells, Cellular Interactions Session II: Single Molecular Recognition, Affinity, Unfolding Forces Session III: High Resolution Imaging Session IV: Model Membranes and Protein Membrane Interactions Francis Steenbeke, Veeco Vice President and Life Science Business Development Manager, commented, "This conference will act as a forum to promote innovative cross linked research and highlight the power of integrating AFM with other optical and analytical techniques in order to solve biological and health care challenges. Veeco’s goal is to remain at the forefront of worldwide cell biology research and to continue to develop innovative AFM solutions for biological research and industrial applications, such as our BioScope™ II AFM.” Of Veeco’s over 8,500 research AFMs installed at universities and nanoscience centers worldwide, approximately 2,000 are currently in use in bioscience applications. Over 2,000 scientific papers have been published in the field of bio-research citing Veeco AFMs. About Veeco Veeco Instruments Inc. provides solutions for nanoscale applications in the worldwide, data storage, HB-LED/wireless, semiconductor and scientific research markets. Our Metrology products are used to measure at the nanoscale and our Process Equipment tools help create nanoscale devices. Veeco's manufacturing and engineering facilities are located in New York, New Jersey, California, Colorado, Arizona and Minnesota. Global sales and service offices are located throughout the United States, Europe, Japan and Asia Pacific. Additional information on Veeco can be found at http://www.veeco.com/. To the extent that this news release discusses expectations about market conditions, market acceptance and future sales of Veeco’s products, Veeco’s future financial performance, future disclosures, or otherwise makes statements about the future, such statements are forward-looking and are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include the challenges of volatility in end market conditions and the cyclical nature of the data storage, semiconductor, HB-LED/wireless and scientific research markets, risks associated with integrating acquired businesses and the acceptance of new products by individual customers and by the marketplace and other factors discussed in the Business Description and Management’s Discussion and Analysis sections of Veeco’s Annual Report on Form 10-K for the year ended December 31, 2005, subsequent Quarterly Reports on Form 10-Q and current reports on Form 8-K. Veeco does not undertake any obligation to update any forward-looking statements to reflect future events or circumstances after the date of such statements.
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Veeco Instruments Inc. 16,50 0,00% Veeco Instruments Inc.

Indizes in diesem Artikel

NASDAQ Comp. 17 710,74 1,52%
S&P 600 SmallCap 935,46 -0,94%